A novel selective PPAR-α agonist, CP900691, improves plasma lipids, lipoproteins, glycemic control and reduces body weight in diabetic monkeys

被引：0
|
作者：
Flynn, Mickey
Shadoan, Melanie K.
Kavanagh, Kylie
Zhang, Li
Auerbach, Bruce J.
Harwood, H. J.
Wagner, Janice D.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A138 / A138
页数：1
相关论文
共 18 条
  • [1] A Selective Peroxisome Proliferator-Activated Receptor α Agonist, CP-900691, Improves Plasma Lipids, Lipoproteins, and Glycemic Control in Diabetic Monkeys
    Wagner, Janice D.
    Shadoan, Melanie K.
    Zhang, Li
    Ward, Gina M.
    Royer, Lori J.
    Kavanagh, Kylie
    Francone, Omar L.
    Auerbach, Bruce J.
    Harwood, H. James, Jr.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (03): : 844 - 853
  • [2] Leptin-Dependent Effects of CP-900691, a Highly Selective and Potent PPAR-α Agonist on Diabetic Nephropathy in the BTBR ob/ob Mouse
    Wietecha, Tomasz
    Hudkins, Kelly L.
    Fox, Edward J.
    Nguyen, Tri Q.
    Loeb, Lawrence A.
    Alpers, Charles E.
    Askari, Bardia
    DIABETES, 2012, 61 : A132 - A133
  • [3] TAAR1 Agonist Ulotaront Improves Glycemic Control and Reduces Body Weight in Rodent Models of Diabetes, Obesity, and Iatrogenic Weight Gain
    Dedic, Nina
    Jones, Philip G.
    Hajos-Korcsok, Eva
    Synan, Colleen
    Wu, Serena
    Anacker, Christoph
    Vickers, Steve P.
    Hecksher-Sorensen, Jacob
    Zeni, Courtney
    Milanovic, Snezana
    Hopkins, Seth C.
    Bristow, Linda J.
    Koblan, Kenneth S.
    CNS SPECTRUMS, 2023, 28 (02) : 259 - 259
  • [4] Ipragliflozin, A Novel SGLT2-Selective Inhibitor, Improves Glycemic Control and Reduces Body Fat in the Diabetic Goto-Kakizaki (GK) Rats
    Takasu, Toshiyuki
    Hayashizaki, Yuka
    Hirosumi, Jiro
    Minoura, Hideaki
    Amino, Nobuaki
    Kurosaki, Eiji
    DIABETES, 2012, 61 : A294 - A295
  • [5] TAAR1 Agonist Ulotaront Improves Glycemic Control, Reduces Body Weight and Modulates Neurocircuits Governing Energy Balance and Feeding in Rodents
    Dedic, Nina
    Hajos-Korcsok, Eva
    Jones, Phil G.
    Synan, Colleen
    Wu, Serena
    Anacker, Christoph
    Vickers, Steven P.
    Hecksher-Sorensen, Jacob
    Milanovic, Snezana
    Bristow, Linda J.
    Koblan, Kenneth S.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 166 - 166
  • [6] TAAR1 Agonist Ulotaront Improves Glycemic Control, Reduces Body Weight and Modulates Neurocircuits Governing Energy Balance and Feeding in Rodents
    Dedic, Nina
    Hajos-Korcsok, Eva
    Jones, Phil G.
    Synan, Colleen
    Wu, Serena
    Anacker, Christoph
    Vickers, Steven P.
    Hecksher-Sorensen, Jacob
    Milanovic, Snezana
    Bristow, Linda J.
    Koblan, Kenneth S.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 166 - 166
  • [7] Tks1225, a novel oxyntomodulin analogue, reduces food intake and body weight and improves glycemic control in dio rats
    Cooke, D.
    Edwards, J.
    Bloom, S.
    Burt, J.
    Olverling, A.
    Tang-Christensen, M.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S73 - S73
  • [8] Novel Oral Small Molecule GLP1 Agonist Reduces Body Weight and Improves Glucose Control in DIO Mice
    Medley, Kyle
    Bearss, David
    Lin, Chenyu
    Vankayalapati, Hariprasad
    OBESITY, 2024, 32 : 166 - 167
  • [9] Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes
    Gerhard, GT
    Ahmann, A
    Meeuws, K
    McMurry, MP
    Duell, PB
    Connor, WE
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (03): : 668 - 673
  • [10] The New Dual Glucagon-GLP-1 Agonist ZP2929 Improves Glycemic Control and Reduces Body Weight in Murine Models of Obesity and Type 2 Diabetes
    Daugaard, Jens R.
    Meier, Eddi
    Riber, Ditte
    Baek, Camilla A. E.
    Larsen, Kjeld S.
    Kampen, Gita
    DIABETES, 2010, 59 : A430 - A430
12